[{"address1": "11711 N. Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 38, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 571200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 578000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven J. Prestrelski M.B.A., MBA, Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Gambino", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Graham", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Dorato DABT, Ph.D.", "title": "Sr. Vice President of Discovery & Non-Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.26, "open": 10.21, "dayLow": 9.8, "dayHigh": 10.79, "regularMarketPreviousClose": 10.26, "regularMarketOpen": 10.21, "regularMarketDayLow": 9.8, "regularMarketDayHigh": 10.79, "payoutRatio": 0.0, "forwardPE": -4.2446356, "volume": 138700, "regularMarketVolume": 138700, "averageVolume": 315871, "averageVolume10days": 202030, "averageDailyVolume10Day": 202030, "bid": 9.7, "ask": 10.03, "bidSize": 1, "askSize": 1, "marketCap": 330498112, "fiftyTwoWeekLow": 8.631, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 12.653, "twoHundredDayAverage": 17.902353, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 53645264, "profitMargins": 0.0, "floatShares": 13610914, "sharesOutstanding": 33417400, "sharesShort": 2799627, "sharesShortPriorMonth": 2030386, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1103, "heldPercentInsiders": 0.03243, "heldPercentInstitutions": 0.98632, "shortRatio": 11.14, "impliedSharesOutstanding": 33417400, "bookValue": 8.131, "priceToBook": 1.2163327, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -55179000, "trailingEps": -1.65, "forwardEps": -2.33, "enterpriseToEbitda": -0.904, "52WeekChange": -0.5661734, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 9.89, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.25, "targetMedianPrice": 37.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 277063008, "totalCashPerShare": 8.291, "ebitda": -59348000, "totalDebt": 210000, "quickRatio": 25.451, "currentRatio": 25.748, "debtToEquity": 0.077, "operatingCashflow": -49790000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -3.6062367, "regularMarketPrice": 9.89, "corporateActions": [], "postMarketTime": 1741381507, "regularMarketTime": 1741381202, "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "MBX Biosciences, Inc.", "marketState": "CLOSED", "shortName": "MBX Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 9.89, "postMarketChange": 0.0, "regularMarketChange": -0.3699999, "regularMarketDayRange": "9.8 - 10.79", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 315871, "fiftyTwoWeekLowChange": 1.2590008, "fiftyTwoWeekLowChangePercent": 0.14586964, "fiftyTwoWeekRange": "8.631 - 27.5", "fiftyTwoWeekHighChange": -17.61, "fiftyTwoWeekHighChangePercent": -0.64036363, "fiftyTwoWeekChangePercent": -56.617336, "earningsTimestampStart": 1730984403, "earningsTimestampEnd": 1730984403, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.65, "epsForward": -2.33, "epsCurrentYear": -13.24512, "priceEpsCurrentYear": -0.74669015, "fiftyDayAverageChange": -2.7629995, "fiftyDayAverageChangePercent": -0.21836714, "twoHundredDayAverageChange": -8.012353, "twoHundredDayAverageChangePercent": -0.44755864, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "cryptoTradeable": false, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]